The US Department of Health and Human Services has introduced SPECTRA, an initiative leveraging AI and technology to track autism development and enable earlier, customised interventions, marking a shift from traditional diagnosis models.
The US Department of Health and Human Services has launched a new autism research programme it says will use artificial intelligence and other technology to follow how the condition develops and to identify earlier points for intervention. The initiative, called SPECTRA, sits under the Advanced Research Projects Agency for Health, or ARPA-H, the department’s fast-track biomedical research arm. In a statement, HHS said the programme is intended to move autism care beyond a one-size-fits-all model and towards more precise diagnosis and treatment.
According to the department, SPECTRA will combine biological, clinical, behavioural and real-world data to map developmental and health trajectories over time. HHS said the work will focus on four areas: analysis, modelling, precision intervention and enabling technologies. Among the tools being considered are privacy-preserving AI platforms, wearable devices and at-home monitoring systems that could help identify patterns earlier and support more targeted care. The department also said the programme is designed to incorporate the lived experience of the autism community.
The proposal arrives as the Trump administration and HHS Secretary Robert F. Kennedy Jr. continue to push for research into the causes of autism, including factors that may be environmental as well as genetic. Bloomberg News, reviewing a draft proposal, reported that the department wants to study the interplay of genetic, biological, environmental and social influences, while Kennedy has rejected the idea that genetics and improved screening alone explain rising autism rates. A spokesperson for HHS declined to comment on the draft when Bloomberg sought a response.
Experts have urged caution about how the work is framed. Alycia Halladay, chief science officer at the Autism Science Foundation, told Bloomberg the draft echoed themes already seen in a recent autism research and policy plan, but said it was not clear how the ideas would be put into practice. She also said it was unclear whether vaccines would be considered among possible environmental factors. Her comments come after a separate federal autism blueprint drew criticism from patient advocates over the speed and process of its adoption. The new effort also follows other recent HHS actions, including a National Institutes of Health initiative and a partnership with the Centres for Medicare and Medicaid Services to study autism using real-world data.
Disclaimer: This content is for informational purposes only and is not intended to be a substitute for professional medical judgment, advice, diagnosis, or treatment.
